A phase I-II Trial of Gleevec (imatinib mesylate) [imatinib] in combination with chlorambucil in previously treated chronic lymphocytic leukemia (CLL) patients.
Phase of Trial: Phase I/II
Latest Information Update: 16 Apr 2010
At a glance
- Drugs Chlorambucil; Imatinib
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 16 Apr 2010 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 27 Nov 2007 New trial record.